In vitro cell-based Hyperuricemia-hemotest bioassay for cytokine status evaluation in patients with gouty arthritis
Authors:
- Larisa Т. VolovaLarisa Т. Volova
- Evgenii I. PugachevEPEvgenii I. Pugachev
- Tatyana V. StarikovaTSTatyana V. Starikova
- Petr А. LebedevPLPetr А. Lebedev
- Irina А. ShafievaISIrina А. Shafieva
- Sergei I. KuznetsovSKSergei I. Kuznetsov
- Oksana А. GusyakovaOGOksana А. Gusyakova
- Galina N. SvetlovaGSGalina N. Svetlova
- Natalya K. OsinaNONatalya K. Osina
- Кузнецов СергейКСКузнецов Сергей
Open Access
- 6 May 2024
- journal article
- research article
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 9 (1) , 14-21
Abstract
Aim– to develop anin vitromethod for assessing the activity of the inflammasome under conditions of hyperuricemic stimulation of inflammatory interleukins. Material and methods.Whole blood cells of donors and patients with hyperuricemia and exacerbation of gouty arthritis diluted with RPMI were culturedin vitroin the presence of different concentrations of uric acid. The production of cytokines in the cell growth media of hematopoietic cells stimulated with uric acid was evaluated using an enzyme-linked immunosorbent assay (ELISA). Results.By simulating the hyperuricemiain vivo, anin vitrocell-based bioassay was developed to stimulate blood cells of individual donors with uric acid. Using the developedin vitroHyperuricemia-hemotest bioassay, quantitative differences were found in the production of inflammatory cytokines by the blood cells of potentially healthy donors and patients with hyperuricemia and gouty arthritis. Conclusion.As a new approach in personalized diagnostics, a hyperuricemic (HU)-hemotest system was developed, which can serve as anin vitrocell model for studying the activation of inflammasome by inflammatory signaling molecules in gouty arthritis.Keywords
This publication has 30 references indexed in Scilit:
- OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activationInflammation Research, 2013
- Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phaseAnnals of the Rheumatic Diseases, 2012
- Interleukin-1 inhibition by anakinra in refractory chronic tophaceous goutInternational Journal of Rheumatic Diseases, 2011
- Epidemiology of gout in women: Fifty‐two–year followup of a prospective cohortArthritis & Rheumatism, 2010
- Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1β by mononuclear cells through a caspase 1-mediated processAnnals of the Rheumatic Diseases, 2009
- Whole-blood culture is a valid low-cost method to measure monocytic cytokines — A comparison of cytokine production in cultures of human whole-blood, mononuclear cells and monocytesJournal of Immunological Methods, 2009
- Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?Medical Hypotheses, 2007
- Uric Acid Is a Risk Factor for Myocardial Infarction and StrokeStroke, 2006
- Gout-associated uric acid crystals activate the NALP3 inflammasomeNature, 2006
- Hyperuricemia in Childhood Primary HypertensionHypertension, 2003